GHRP-6 and GHRP-2 Primary benefits for strength: Powerful growth hormone release Significant muscle mass gains Increased appetite (helps with bulking) Strong recovery enhancement Dosing for strength: 100-300mcg, 2-3 times daily Best on empty stomach Powerful when stacked with CJC-1295 Timeline for strength gains: Faster muscle gains than Ipamorelin 8-16 weeks for significant strength improvements More aggressive muscle building Best for: Bulking phases Athletes who want aggressive muscle gain Those who can manage increased appetite Downsides: Increases prolactin (monitor for side effects) Very strong hunger (can be pro or con) Hexarelin Primary benefits for strength: Most powerful GHRP for GH release Rapid muscle growth Significant strength gains Enhanced recovery Dosing for strength: 100-200mcg, 2-3 times daily Cycle for 4-8 weeks, then break (desensitization occurs) Extremely potent Timeline for strength gains: Faster than other GHRPs 4-8 weeks for noticeable strength increase Requires cycling to maintain effectiveness Best for: Short-term strength boosts Experienced peptide users Aggressive bulking phases Downsides: Desensitization with continuous use Increases cortisol and prolactin more than other GHRPs Requires breaks IGF-1 LR3: The most anabolic peptide for strength IGF-1 LR3 is in a category by itself for muscle and strength building

As a leading supplier of research peptides in Europe, Peptide Koning ensures that every batch of Ahk Cu meets the highest standards of purity and quality
For confirmed B12 deficiency without neurological involvement , the standard regimen comprises 1 mg hydroxocobalamin intramuscularly three times weekly for two weeks, followed by maintenance doses every two to three months for those with irreversible causes like pernicious anaemia
Patients focused on long-term metabolic health sometimes pair MOTS-c with GHK-Cu, a copper peptide that targets tissue repair, collagen production, and anti-aging at the cellular matrix level through a completely separate mechanism
This modulation appears selective, as AOD 9604 does not activate the growth hormone receptor or induce downstream IGF-1 signaling